[Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
Gurevich
M A
MA
Department of Therapy, Faculty of Advanced Training for Doctors, MONIKI of MV Vladimirskii.
Iankovskaia
M O
MO
Gordienko
B V
BV
Mravian
S R
SR
Grigor'eva
N M
NM
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006439:Hemodynamics; D006801:Humans; D009205:Myocarditis / Q000188:drug therapy* / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004232:Diuretics
Osobennosti lecheniia serdechnoi nedostatochnosti pri diffusnykh miokarditakh i dillatatsionnoi kardiomiopatii.